Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

NEZOMED PHARMACEUTICALS

Class 35Status: Accepted & Advertised
Trademark Logo
Application Number6374071
Trademark Status
Accepted & Advertised
Trademark Class35
Application Date2024-04-04
Proprietor NameMR. BABUL DEBNATH
Appropriate OfficeKOLKATA
StateASSAM
Trademark TypeDEVICE
User DetailsProposed to be used
Agent NameMAA SHARDA ASSOCIATES[25028]
Agent Address303 WESTEND CORPORATE BUILDING OPPOSITE APNA SWEETS NEW PALASIA INDORE (M.P.) 452001
Goods And Services Details[CLASS : 35] ADVERTISING, MARKETING, WHOLESALING, RETAILING, SALES PROMOTION, BUSINESS MANAGEMENT, OUTLET RELATED TO MEDICINAL AND PHARMACEUTICALS PREPARATIONS.

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
NEZOMED PHARMACEUTICALS35Accepted & Advertised

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about NEZOMED PHARMACEUTICALS.

The current status of trademark application 6374071 for NEZOMED PHARMACEUTICALS is Accepted & Advertised.
NEZOMED PHARMACEUTICALS is registered under trademark class 35.
The proprietor of NEZOMED PHARMACEUTICALS is MR. BABUL DEBNATH.
Trademark application 6374071 for NEZOMED PHARMACEUTICALS was filed on 2024-04-04.